Skip to main content
BioAdvance NewsPortfolio NewsVenatorx Pharmaceuticals

Venatorx Pharmaceuticals Highlights Two Recent Publications Indicating Rising Metallo-Beta-Lactamases for Carbapenem-Resistant Enterobacterales in US

By August 14, 2023November 1st, 2024No Comments

Venatorx Pharmaceuticals Highlights Two Recent Publications Indicating Rising Metallo-Beta-Lactamases for Carbapenem-Resistant Enterobacterales in US

Growing Global Incidence of Carbapenem-Resistant Enterobacterales Metallo-beta-lactamases were the most frequently identified carbapenem resistance
mechanism among Enterobacterales isolates in IHMA global surveillance 

See more here